CClinicalTrials.gg
CompletedNCT05346692Updated Jan 14, 2025

Digital Meditation for Postoperative Pain Control After Abdominal Surgery for Cancer

An Early Phase 1 interventional study of Survey Administration and Interview in Hematopoietic and Lymphoid System Neoplasm and Malignant Solid Neoplasm, sponsored by Emory University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-01-14.

Sponsored by Emory University · Early Phase 1, Interventional, and Supportive care

Phase
Early Phase 1
Study type
Interventional
Enrollment
73
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This phase I trial tests a digital meditation for postoperative pain control after abdominal surgery for cancer. Mindfulness interventions such as guided meditation may improve pain control and decrease stress. Including a brief mindfulness intervention administered via test messages as part of postoperative care may improve pain severity, decrease opioid use, and improve patient responses to non-surgical treatments.

Read the detailed description

PRIMARY OBJECTIVES:

I. To investigate and define anticipated and unanticipated adverse events (AEs) related to a daily virtual mindfulness intervention delivered via short message service (SMS) text messaging and to test its safety in the postoperative period amongst patients with cancer.

II. To determine the feasibility and acceptability of a novel, brief mindfulness intervention delivered via SMS text messaging in the postoperative period amongst patients undergoing surgery for cancer.

III. To determine the feasibility and acceptability of an artificial intelligence platform to deliver and receive SMS text messages for the purpose of delivering pain assessment tools and collecting and storing pain-specific and patient reported outcomes.

OUTLINE: Patients are assigned to 1 of 2 arms. ARM I: Patients complete pain survey via text message daily for 10 days after surgery. Patients also complete telephone interview 2 weeks after surgery.

ARM II: Patients complete mindfulness intervention via text message daily for 10 days after surgery. Patients also complete telephone interview 2 weeks after surgery.

02

Conditions studied

  • Hematopoietic and Lymphoid System Neoplasm
  • Malignant Solid Neoplasm

Browse trials for

03

In context

Neoplasms

9,365 studies on the registry are indexed under Neoplasms; 2,489 are open to participants now.

This study's enrollment of 73 is above the median of 50 across 7,253 interventional studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

Emory University is the lead sponsor of 1,386 studies on the registry; 236 are open to participants now.

Of its 229 completed or terminated interventional studies of FDA-regulated products, 174 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients >= 18 years of age
  • Open abdominal surgery for cancer
  • Ownership of smartphone (iOS or Android operating systems) with SMS texting capabilities
  • Ability to read
  • Ability to understand the purposes and risk of the study and willingly give standard written informed consent for treatment established by each participating institution.

Exclusion criteria

Exclusion Criteria:

  • Patients with contraindications to abdominal surgery and/or general anesthesia
05

Study design

Phase
Early Phase 1
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
73 participants (actual)

Study arms

  • Active comparator
    Arm I (Pain Survey)

    Patients complete pain survey via text message daily for 10 days after surgery. Patients also complete telephone interview 2 weeks after surgery.

    Other: Survey Administration · Other: Interview

  • Experimental
    Arm 2 (Mindfulness Intervention)

    Patients complete mindfulness intervention via text message daily for 10 days after surgery. Patients also complete telephone interview 2 weeks after surgery.

    Other: Text Message-Based Navigation Intervention · Other: Interview

Interventions

  • OtherSurvey Administration

    Complete Survey

  • OtherInterview

    Complete Interview

  • OtherText Message-Based Navigation Intervention

    Complete mindfulness intervention

    Also known as: Automated Text Message-Based Navigation, Text Message-Based Navigation

  • OtherInterview

    Complete interview

06

What researchers measure

Primary outcomes

  1. Incidence of adverse events

    Adverse events (AEs) will be reported, and summarized using frequencies and percentages. An AE will be considered unexpected if the nature, severity, or frequency of the event is not consistent with the risk information previously described for the study intervention. Unexpected AEs will be summarized descriptively. The most common adverse events reported within the mindfulness literature anxiety, depression, and cognitive anomalies. The overall prevalence of meditation adverse events is 8%, which is similar to those reported for psychotherapy practice in general.

    Time frame: Up to 12 months

  2. Feasibility of intervention and mode of delivery

    Feasibility for each arm is defined as completion of at least 50% of the program.The proportion completing at least 50% of the program will be compared to a null proportion of 20% completing at least 50% of the program using a one-sample Z-test.

    Time frame: Up to 12 months

Secondary outcomes

  1. Intervention and mode of delivery utilizing the Client Satisfaction Survey (CSQ-8)

    Acceptability of intervention and mode of delivery will include quantitative and qualitative analyses. Quantitative analysis will include the Client Satisfaction Survey (CSQ-8). The CSQ-8 focuses on participant satisfaction with the intervention received, including: 1. the overall quality 2. perception of the program's ability to meet their needs 3. amount of help received 4. the extent to which this program helped them deal with recovery after surgery. The CSQ-8 has demonstrated good internal consistency, test-retest reliability, and sensitivity10.

    Time frame: Up to 12 months

  2. Intervention and mode of delivery utilizing the System Usability Scale (SUS)

    Acceptability of intervention and mode of delivery will include quantitative and qualitative analyses. Quantitative analysis will include the System Usability Scale (SUS) administered to all participants at study completion of the study to all participants. The SUS is a 10-item scale that examines the perceived usability of a technology and is commonly used in evaluating mobile apps. The SUS has demonstrated good reliability in other studies.

    Time frame: Up to 12 months

07

Study locations

1 site
  • Emory University/Winship Cancer Institute
    Atlanta, Georgia 30322, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 14, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05346692
Lead sponsor
Emory University
Collaborators
National Cancer Institute (NCI)
Responsible party
Viraj Master (Principal Investigator, Emory University) — Principal investigator
First posted
Apr 26, 2022
Start date
Mar 28, 2022
Primary completion
Jul 12, 2023
Completion
Jul 12, 2023
Last update
Jan 14, 2025

Study contacts

Maggie Diller, MD
principal investigator · Emory University/Winship Cancer Institute

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion